Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...

Multiple myeloma is a relatively uncommon cancer of plasma cells, where excessive proliferation of these malignant cells within the bone marrow leads to abnormal antibody production. The disease ...

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence. Despite its rarity and the lack of recognition by the World Health Organization as a ...

When Mateo Mejia Saldarriaga, MD, first started seeing multiple myeloma (MM) patients as a medical student in his native Colombia 10 years ago, he was intrigued by the multifaceted nature of this ...

Current research tests how TACI variants modify immunity to transplants and in host defense. C3d Immunotherapies to treat multiple myeloma and related conditions. In a separate line of investigation, ...

B-cell maturation antigen–directed chimeric antigen receptor (CAR) T-cell therapy demonstrated safety in patients with multiple myeloma (MM) and central nervous system (CNS) involvement ...